FAN Bulletin #597
May 19, 2006
Daniel G. Stockin, MPH
Senior Operations Officer
The Lillie Center, Inc.
P.O. Box 1951
Brentwood, TN 37024
Dear Mr. Stockin,
Thank you for your interest in the recent National Research Council report on the toxicology of fluoride; as you know, I had the privilege of serving on the committee that prepared this report. As a resident of Tennessee for 25 years, I appreciate your concern regarding the significance of the NRC report for water districts in Tennessee that are evaluating the safety and desirability of starting or continuing water fluoridation.
As you are aware, the NRC report did not evaluate the safety or benefits of water fluoridation, which were outside the scope of our committee’s assignment. However, we also did not say that the practice of fluoridation is safe or that fluoride concentrations in water of 0.7-1.2 mg/L are safe-we did not evaluate that. We did specifically address the safety of the Maximum Contaminant Level Goal (MCLG) of 4 mg/L, and we concluded, unanimously, that the MCLG is not protective of human health. We said that the MCLG should be lowered, but we did not derive or suggest a new value for the MCLG.
Our conclusion that the MCLG of 4 mg/L is not protective was based largely on health effects that have long been considered specific to fluoride and significant enough to warrant protection, namely dental fluorosis and skeletal fluorosis. We parted ways with previous reviews of fluoride by saying that severe dental fluorosis is an adverse health effect, not merely a cosmetic effect, that stage II as well as stage III skeletal fluorosis is an adverse health effect, and that a fluoride concentration of 4 mg/L is likely not protective with respect to an increased risk of bone fracture. We indicated that at 2 or 4 mg/L, bone fluoride concentrations can reach the ranges historically associated with stage II and III skeletal fluorosis. We were not able to rule out a carcinogenic effect of fluoride. We reported that fluoride exposure is plausibly associated with a number of other health effects, including neurotoxicity, gastrointestinal problems, and endocrine problems, and that even though these effects are not necessarily specific to fluoride exposure, the associations cannot be ruled out and need further study.
For dental fluorosis, skeletal fluorosis, and risk of bone fracture, the committee considered studies in which populations were exposed to concentrations of fluoride in drinking water of around 4 mg/L; because there were sufficient studies at the exposure level of interest, we did not examine the whole range of possible fluoride exposures. From those studies we concluded that 4 mg/L is not protective of those effects; only when the fluoride concentration in water is below 2 mg/L does the prevalence of severe dental fluorosis approach zero. For some of the other health effects mentioned above, the committee examined studies over a wider range of exposures, depending on what information was available. Some of those studies do include exposure levels that would be associated with water fluoride concentrations of around 1 mg/L. The committee also provided a very thorough analysis of overall fluoride exposures in the U.S., which are largely driven by drinking water and beverages made with tap water. We identified population subgroups who are at higher risk than usual of problems due to fluoride exposure, due to factors such as very high water consumption rates or increased retention of fluoride in the body.
Sincerely,
Senior Scientist
(865) 483-6111







